William Fay is a Cardiology physician affiliated with Harry S. Truman Memorial Veterans' Hospital. OpenAlex indexes 138 publications with 7,001 citations (h-index 44).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Hospital Dr
Columbia, MO 652120001
Telephone
573-882-2296Registry record last updated 14 Sept 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Siemens Medical Solutions USA, Inc.Program year20252 payments
- Amgen Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
6 NIH research awards on record, funded 2004–2025 per NIH RePORTER. The latest:
- Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
Harry S. Truman Memorial Va Hospital
FY2025I01BX005144 - Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
Harry S. Truman Memorial Va Hospital
FY2024I01BX005144 - Midwest Biomedical Accelerator Consortium: MBArC
University of Missouri-Columbia
FY2023$123,892U01HL152410
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome
Arteriosclerosis Thrombosis and Vascular Biology
2020 - Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling
Journal of Biological Chemistry
2017 - Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis
International Journal of Molecular Sciences
2016 - Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation
Arteriosclerosis Thrombosis and Vascular Biology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Matthew Bechtold, MD
Harry S. Truman Memorial Veterans' Hospital
Guido Lastra Gonzalez, MD
Harry S. Truman Memorial Veterans' Hospital
Poorna Karuparthi, MD
Harry S. Truman Memorial Veterans' Hospital
Nathan Hesemann, MD
Harry S. Truman Memorial Veterans' Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”